122 related articles for article (PubMed ID: 26944156)
1. Relevance of endoglin, IL-1α, IL-1β and anti-ovarian antibodies in females with multiple sclerosis.
Thöne J; Kleiter I; Stahl A; Ellrichmann G; Gold R; Hellwig K
J Neurol Sci; 2016 Mar; 362():240-3. PubMed ID: 26944156
[TBL] [Abstract][Full Text] [Related]
2. Serum anti-Müllerian hormone levels in reproductive-age women with relapsing-remitting multiple sclerosis.
Thöne J; Kollar S; Nousome D; Ellrichmann G; Kleiter I; Gold R; Hellwig K
Mult Scler; 2015 Jan; 21(1):41-7. PubMed ID: 25145691
[TBL] [Abstract][Full Text] [Related]
3. Ovarian reserve assessment in users of oral contraception seeking fertility advice on their reproductive lifespan.
Birch Petersen K; Hvidman HW; Forman JL; Pinborg A; Larsen EC; Macklon KT; Sylvest R; Andersen AN
Hum Reprod; 2015 Oct; 30(10):2364-75. PubMed ID: 26311148
[TBL] [Abstract][Full Text] [Related]
4. Thyroid autoimmunity, hypothyroidism and ovarian reserve: a cross-sectional study of 5000 women based on age-specific AMH values.
Polyzos NP; Sakkas E; Vaiarelli A; Poppe K; Camus M; Tournaye H
Hum Reprod; 2015 Jul; 30(7):1690-6. PubMed ID: 25948573
[TBL] [Abstract][Full Text] [Related]
5. Pituitary-ovary axis and ovarian reserve in fertile women with multiple sclerosis: A pilot study.
Sepúlveda M; Ros C; Martínez-Lapiscina EH; Solà-Valls N; Hervàs M; Llufriu S; La Puma D; Casals E; Blanco Y; Villoslada P; Graus F; Castelo-Branco C; Saiz A
Mult Scler; 2016 Apr; 22(4):564-8. PubMed ID: 26362892
[TBL] [Abstract][Full Text] [Related]
6. Serum anti-Mullerian hormone assessment of ovarian reserve and polycystic ovary syndrome status over the reproductive lifespan.
Tremellen K; Zander-Fox D
Aust N Z J Obstet Gynaecol; 2015 Aug; 55(4):384-9. PubMed ID: 26230428
[TBL] [Abstract][Full Text] [Related]
7. Increased serum level of IL-37 in patients with multiple sclerosis and neuromyelitis optica.
Farrokhi M; Rezaei A; Amani-Beni A; Etemadifar M; Kouchaki E; Zahedi A
Acta Neurol Belg; 2015 Dec; 115(4):609-14. PubMed ID: 26008726
[TBL] [Abstract][Full Text] [Related]
8. Ovarian reserve alterations in premenopausal women with chronic inflammatory rheumatic diseases: impact of rheumatoid arthritis, Behçet's disease and spondyloarthritis on anti-Müllerian hormone levels.
Henes M; Froeschlin J; Taran FA; Brucker S; Rall KK; Xenitidis T; Igney-Oertel A; Lawrenz B; Henes JC
Rheumatology (Oxford); 2015 Sep; 54(9):1709-12. PubMed ID: 25957439
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-1 deficiency prolongs ovarian lifespan in mice.
Uri-Belapolsky S; Shaish A; Eliyahu E; Grossman H; Levi M; Chuderland D; Ninio-Many L; Hasky N; Shashar D; Almog T; Kandel-Kfir M; Harats D; Shalgi R; Kamari Y
Proc Natl Acad Sci U S A; 2014 Aug; 111(34):12492-7. PubMed ID: 25114230
[TBL] [Abstract][Full Text] [Related]
10. Assessment of anti-Müllerian hormone levels in premenopausal patients with systemic lupus erythematosus.
Gasparin AA; Souza L; Siebert M; Xavier RM; Chakr RM; Palominos PE; Brenol JC; Monticielo OA
Lupus; 2016 Mar; 25(3):227-32. PubMed ID: 26223296
[TBL] [Abstract][Full Text] [Related]
11. Relative importance of AMH and androgens changes with aging among non-obese women with polycystic ovary syndrome.
Kushnir VA; Halevy N; Barad DH; Albertini DF; Gleicher N
J Ovarian Res; 2015 Jul; 8():45. PubMed ID: 26156856
[TBL] [Abstract][Full Text] [Related]
12. Cystic fibrosis (cf) and ovarian reserve: A cross-sectional study examining serum anti-mullerian hormone (amh) in young women.
Schram CA; Stephenson AL; Hannam TG; Tullis E
J Cyst Fibros; 2015 May; 14(3):398-402. PubMed ID: 25280785
[TBL] [Abstract][Full Text] [Related]
13. Reduced ovarian reserve in patients with Takayasu arteritis.
Mont'Alverne AR; Pereira RM; Yamakami LY; Viana VS; Baracat EC; Bonfá E; Silva CA
J Rheumatol; 2014 Oct; 41(10):2055-9. PubMed ID: 25128515
[TBL] [Abstract][Full Text] [Related]
14. Ovarian reserve after treatment with alkylating agents during childhood.
Thomas-Teinturier C; Allodji RS; Svetlova E; Frey MA; Oberlin O; Millischer AE; Epelboin S; Decanter C; Pacquement H; Tabone MD; Sudour-Bonnange H; Baruchel A; Lahlou N; De Vathaire F
Hum Reprod; 2015 Jun; 30(6):1437-46. PubMed ID: 25801499
[TBL] [Abstract][Full Text] [Related]
15. The effects of hydroxyurea and bone marrow transplant on Anti-Müllerian hormone (AMH) levels in females with sickle cell anemia.
Elchuri SV; Williamson RS; Clark Brown R; Haight AE; Spencer JB; Buchanan I; Hassen-Schilling L; Brown MR; Mertens AC; Meacham LR
Blood Cells Mol Dis; 2015 Jun; 55(1):56-61. PubMed ID: 25976468
[TBL] [Abstract][Full Text] [Related]
16. Anti-Müllerian hormone in reproductive age women with systemic lupus erythematosus.
Velarde-Ochoa Mdel C; Esquivel-Valerio JA; Vega-Morales D; Skinner-Taylor CM; Galarza-Delgado DÁ; Garza-Elizondo MA
Reumatol Clin; 2015; 11(2):78-82. PubMed ID: 24815955
[TBL] [Abstract][Full Text] [Related]
17. Antimullerian hormone in cases of different reproductive pathologies.
Barbakadze L; Kristasashvili J
Georgian Med News; 2014; (232-233):16-21. PubMed ID: 25214265
[TBL] [Abstract][Full Text] [Related]
18. Age at menarche and parity are independently associated with Anti-Müllerian hormone, a marker of ovarian reserve, in Filipino young adult women.
Bragg JM; Kuzawa CW; Agustin SS; Banerjee MN; McDade TW
Am J Hum Biol; 2012; 24(6):739-45. PubMed ID: 22915230
[TBL] [Abstract][Full Text] [Related]
19. Comparison of markers of ovarian reserve between patients with complete müllerian agenesis and age-matched fertile and infertile controls.
Ozekinci M; Erman Akar M; Senol Y; Ozdem S; Uzun G; Daloglu A; Ongut G
Fertil Steril; 2015 Jul; 104(1):176-9. PubMed ID: 26025811
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of ovarian reserve in Hashimoto's thyroiditis.
Tuten A; Hatipoglu E; Oncul M; Imamoglu M; Acikgoz AS; Yilmaz N; Ozcil MD; Kaya B; Misirlioglu AM; Sahmay S
Gynecol Endocrinol; 2014 Oct; 30(10):708-11. PubMed ID: 24905723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
